Treatment options for chronic hepatitis. Antivirals look promising.

作者信息

Zuckerman A J, Lavanchy D

出版信息

BMJ. 1999 Sep 25;319(7213):799-800. doi: 10.1136/bmj.319.7213.799.

DOI:10.1136/bmj.319.7213.799

PMID:10496806

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1116648/

Abstract

摘要

相似文献

Treatment options for chronic hepatitis. Antivirals look promising.

BMJ. 1999 Sep 25;319(7213):799-800. doi: 10.1136/bmj.319.7213.799.

How to compare antivirals in the treatment of chronic hepatitis B?

Ann Clin Microbiol Antimicrob. 2009 Mar 2;8:6. doi: 10.1186/1476-0711-8-6.

[Focusing on antiviral options for the treatment of chronic hepatitis B].

Zhonghua Gan Zang Bing Za Zhi. 2006 May;14(5):321-2.

[A primer on the management of antiviral resistance in chronic hepatitis B].

Rev Med Suisse. 2009 Jan 21;5(187):203-4, 206-8,.

Hepatitis B virus - recent therapeutic advances and challenges to cure.

J Hepatol. 2020 Sep;73(3):694-695. doi: 10.1016/j.jhep.2020.04.015. Epub 2020 Jul 16.

Adherence to oral antivirals in patients with chronic hepatitis B infection.

Indian J Gastroenterol. 2014 Jul;33(4):390-1. doi: 10.1007/s12664-013-0433-z.

Treatment options for chronic hepatitis B not responding to interferon.

J Hepatol. 2003 Jun;38(6):853-5. doi: 10.1016/s0168-8278(03)00156-9.

Advances in new antivirals for chronic hepatitis B.

Chin Med J (Engl). 2022 Feb 2;135(5):571-583. doi: 10.1097/CM9.0000000000001994.

Outcome of patients suffering from a spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure and treated with antivirals.

Hepatology. 2011 Sep 2;54(3):1108-9. doi: 10.1002/hep.24328. Epub 2011 Jun 27.

Oral antivirals for chronic hepatitis B.

Clin Liver Dis. 2007 Nov;11(4):851-68, ix. doi: 10.1016/j.cld.2007.08.003.

引用本文的文献

Expression of hepatitis B virus 1.3-fold genome plasmid in an SV40 T-antigen-immortalized mouse hepatic cell line.

World J Gastroenterol. 2013 Nov 28;19(44):8020-7. doi: 10.3748/wjg.v19.i44.8020.

In vitro resistance to interferon of hepatitis B virus with precore mutation.

World J Gastroenterol. 2005 Feb 7;11(5):649-55. doi: 10.3748/wjg.v11.i5.649.

Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.

J Virol. 2001 Jun;75(11):5108-18. doi: 10.1128/JVI.75.11.5108-5118.2001.

本文引用的文献

Lamivudine for hepatitis B in clinical practice.

J Med Virol. 2000 Jul;61(3):386-91. doi: 10.1002/1096-9071(200007)61:3<386::aid-jmv18>3.0.co;2-x.

A dose ranging study of the pharmacokinetics, safety, and preliminary efficacy of lamivudine in children and adolescents with chronic hepatitis B.

Antimicrob Agents Chemother. 2000 Mar;44(3):590-7. doi: 10.1128/AAC.44.3.590-597.2000.

Lamivudine treatment of chronic hepatitis B.

Rev Med Virol. 1998 Jul;8(3):153-159. doi: 10.1002/(sici)1099-1654(199807/09)8:3<153::aid-rmv228>3.0.co;2-y.

Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.

Hepatology. 1999 May;29(5):1581-6. doi: 10.1002/hep.510290507.

A pill a day, or two, for hepatitis B?

Lancet. 1999 Mar 27;353(9158):1032-3. doi: 10.1016/S0140-6736(98)00294-3.

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

N Engl J Med. 1998 Jul 9;339(2):61-8. doi: 10.1056/NEJM199807093390201.

Interferon-alpha2b therapy is efficacious in Asian-Americans with chronic hepatitis B infection: a prospective controlled trial.

Dig Dis Sci. 1998 Apr;43(4):875-9. doi: 10.1023/a:1018894804569.

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective.

Hepatology. 1998 Feb;27(2):628-33. doi: 10.1002/hep.510270243.

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis.

Lancet. 1996 Nov 2;348(9036):1212-5. doi: 10.1016/s0140-6736(96)04444-3.

Efficacy of low-dose alpha interferon therapy in HBV-related chronic liver disease in Asian Indians: a randomized controlled trial.

J Hepatol. 1996 Apr;24(4):391-6. doi: 10.1016/s0168-8278(96)80158-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验